Market Analysis — JOHNS HOPKINS BAYVIEW MED. CTR.
MD market | 10 hospitals | HHI: 2,219 (Moderate)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
10
Hospitals in Market
3,320
Total Beds
$7.0B
Market Revenue
Moderate
HHI: 2,219
Narrow
Moat Rating (5/10)
#3
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantagemoderate
Switching Costshigh
Market Share9.4%
Top 3 Concentration71.4%
Network Density0.30
Margin vs Market-2.4%
Bed Util vs Market+11.8%
What This Means
This hospital has a narrow moat — narrow moat — some competitive advantages, but vulnerable to new entrants. The MD market is moderately concentrated — oligopoly dynamics, negotiating leverage exists (HHI: 2,219).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full MD market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| THE JOHNS HOPKINS HOSPITAL | 1038 | $2,466M | 35.4% | 31.3% |
| UNIVERSITY OF MARYLAND MED SYS | 779 | $1,850M | 26.6% | 23.5% |
| MERCY MEDICAL CENTER | 173 | $561M | 8.1% | 5.2% |
| ST. AGNES HOSPITAL | 183 | $507M | 7.3% | 5.5% |
| MEDSTAR UNION MEMORIAL HOSPITAL | 191 | $409M | 5.9% | 5.8% |
| MARYLAND GENERAL HOSPITAL | 201 | $232M | 3.3% | 6.0% |
| MEDSTAR HARBOR HOSPITAL | 142 | $178M | 2.6% | 4.3% |
| LEVINDAL HEBREW GER. CTR. & HOSPT. | 120 | $88M | 1.3% | 3.6% |
| BON SECOURS HOSPITAL | 69 | $19M | 0.3% | 2.1% |
Regional Payer Mix
■ Medicare 35%■ Medicaid 9%■ Commercial 55%